TY - JOUR
T1 - Postoperative speech impairment and cranial nerve deficits after secondary surgery of posterior fossa tumours in childhood
T2 - a prospective European multicentre study
AU - Grønbæk, J Kjær
AU - Toescu, S
AU - Frič, R
AU - Nilsson, P
AU - Castor, C
AU - Mallucci, C
AU - Pizer, B
AU - Aquilina, K
AU - Molinari, E
AU - Hjort, M Aasved
AU - Karppinen, A
AU - Rutkauskiene, G
AU - Mudra, K
AU - Markia, B
AU - van Baarsen, K
AU - Hoving, E
AU - Zipfel, J
AU - Wibroe, M
AU - Nysom, K
AU - Schmiegelow, K
AU - Sehested, A
AU - Mathiasen, R
AU - Juhler, M
N1 - Funding Information:
This study was funded by The Danish Childhood Cancer Foundation, The Swedish Childhood Cancer Foundation, The Brain Tumour Charity (UK), The Danish Cancer Society, King Christian IX and Queen Louise’s anniversary grant, The Danish Capitol Regions Research Fund, Dagmar Marshall foundation and Rigshospitalet's Research Fund in support of oncology purposes and Brainstrust (SCOT). Børnecancerfonden, 2012–9, 2014–3, 2015–14, 2016–0143, 2018–3653, 2020–6732, Barncancerfonden, PR2012-0106,KP2019-0014, Brain Tumour Charity, Kræftens Bekæmpelse, R124-A7920-15-S2, King Christian IX and Queen Louise’s anniversary grant, the Danish Capitol Regions Research Fund, Dagmar Marshall Foundation,Rigshospitalet’s Research Fund in support of oncology purposes, Braintrust. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. This work is part of Childhood Oncology Network Targeting Research, Organization & Life expectancy (CONTROL) and supported by Danish Cancer Society (R-257-A14720) and the Danish Childhood Cancer Foundation (2019–5934). The funding bodies had no role in the design of the study, analyses, interpretation of the data or decision to submit results.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2022/4
Y1 - 2022/4
N2 - PURPOSE: Brain tumours constitute 25% of childhood neoplasms, and half of them are in the posterior fossa. Surgery is a fundamental component of therapy, because gross total resection is associated with a higher progression-free survival. Patients with residual tumour, progression of residual tumour or disease recurrence commonly require secondary surgery. We prospectively investigated the risk of postoperative speech impairment (POSI) and cranial nerve dysfunction (CND) following primary and secondary resection for posterior cranial fossa tumours.METHODS: In the Nordic-European study of the cerebellar mutism syndrome, we prospectively included children undergoing posterior fossa tumour resection or open biopsy in one of the 26 participating European centres. Neurological status was assessed preoperatively, and surgical details were noted post-operatively. Patients were followed up 2 weeks, 2 months and 1 year postoperatively. Here, we analyse the risk of postoperative speech impairment (POSI), defined as either mutism or reduced speech, and cranial nerve dysfunction (CND) following secondary, as compared to primary, surgery.RESULTS: We analysed 426 children undergoing primary and 78 undergoing secondary surgery between 2014 and 2020. The incidence of POSI was significantly lower after secondary (12%) compared with primary (28%, p = 0.0084) surgery. In a multivariate analysis adjusting for tumour histology, the odds ratio for developing POSI after secondary surgery was 0.23, compared with primary surgery (95% confidence interval: 0.08-0.65, p = 0.006). The frequency of postoperative CND did not differ significantly after primary vs. secondary surgery (p = 0.21).CONCLUSION: Children have a lower risk of POSI after secondary than after primary surgery for posterior fossa tumours but remain at significant risk of both POSI and CND. The present findings should be taken in account when weighing risks and benefits of secondary surgery for posterior fossa tumours.
AB - PURPOSE: Brain tumours constitute 25% of childhood neoplasms, and half of them are in the posterior fossa. Surgery is a fundamental component of therapy, because gross total resection is associated with a higher progression-free survival. Patients with residual tumour, progression of residual tumour or disease recurrence commonly require secondary surgery. We prospectively investigated the risk of postoperative speech impairment (POSI) and cranial nerve dysfunction (CND) following primary and secondary resection for posterior cranial fossa tumours.METHODS: In the Nordic-European study of the cerebellar mutism syndrome, we prospectively included children undergoing posterior fossa tumour resection or open biopsy in one of the 26 participating European centres. Neurological status was assessed preoperatively, and surgical details were noted post-operatively. Patients were followed up 2 weeks, 2 months and 1 year postoperatively. Here, we analyse the risk of postoperative speech impairment (POSI), defined as either mutism or reduced speech, and cranial nerve dysfunction (CND) following secondary, as compared to primary, surgery.RESULTS: We analysed 426 children undergoing primary and 78 undergoing secondary surgery between 2014 and 2020. The incidence of POSI was significantly lower after secondary (12%) compared with primary (28%, p = 0.0084) surgery. In a multivariate analysis adjusting for tumour histology, the odds ratio for developing POSI after secondary surgery was 0.23, compared with primary surgery (95% confidence interval: 0.08-0.65, p = 0.006). The frequency of postoperative CND did not differ significantly after primary vs. secondary surgery (p = 0.21).CONCLUSION: Children have a lower risk of POSI after secondary than after primary surgery for posterior fossa tumours but remain at significant risk of both POSI and CND. The present findings should be taken in account when weighing risks and benefits of secondary surgery for posterior fossa tumours.
KW - Cerebellar Neoplasms/surgery
KW - Child
KW - Cranial Fossa, Posterior/surgery
KW - Cranial Nerves
KW - Humans
KW - Infratentorial Neoplasms/complications
KW - Mutism/epidemiology
KW - Neoplasm Recurrence, Local
KW - Postoperative Complications/epidemiology
KW - Prospective Studies
KW - Speech
KW - Posterior fossa tumour
KW - Cerebellar mutism syndrome
KW - Secondary resection
KW - Posterior fossa syndrome
UR - http://www.scopus.com/inward/record.url?scp=85127999822&partnerID=8YFLogxK
U2 - 10.1007/s00381-022-05464-0
DO - 10.1007/s00381-022-05464-0
M3 - Article
C2 - 35157109
SN - 0256-7040
VL - 38
SP - 747
EP - 758
JO - Childs Nervous System
JF - Childs Nervous System
IS - 4
ER -